BlueCrest Capital Management’s Gyre Therapeutics GYRE Stock Holding History

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Shares Change %	Capital Flow	Portfolio Weight	Portfolio Position
2018 Q2	–	Sell	-1,590	Closed	-$308K	–	1589
2018 Q1	$308K	Buy	+1,590	New	+$308K	0.01%	1014